SCHEMBL35211855

SCHEMBL35211855

CC(C)n1c(=O)c(C(N)=O)cc2ccncc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
SIRT3 Q9NTG7 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
HTR4 Q13639 6/20 0.39
CDK8 P49336 2/20 0.39
CCNC P24863 1/20 0.39
HASPIN Q8TF76 1/20 0.39
MKNK1 Q9BUB5 2/20 0.38
MKNK2 Q9HBH9 2/20 0.38
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
ABL1 P00519 1/20 0.38
RET P07949 1/20 0.38
PIM1 P11309 1/20 0.38
FGFR1 P11362 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35211579 0.82 KDM4E (0.48) KDM4EHTTSIRT3TDP1CDK8
SCHEMBL30337559 0.80 HTR4 (0.56) HTTHTR4IRAK4
SCHEMBL35211826 0.73 SIRT3 (0.45) KDM4EHTTSIRT3TDP1CDK8
SCHEMBL31139853 0.69 HASPIN (0.42) KDM4EHTTSIRT3TDP1HASPIN
SCHEMBL30196438 0.69 IRAK4 (0.69) MKNK1MKNK2IRAK4
SCHEMBL18427749 0.69 IRAK4 (0.69) MKNK1MKNK2IRAK4
SCHEMBL29523063 0.69 KDM4E (0.46) KDM4EHTTSIRT3TDP1CDK8
SCHEMBL22792640 0.68 DHFR (0.46) KDM4EHTTHASPINGSK3BDYRK1A
SCHEMBL3805086 0.68 AURKA (0.35) KDM4EHTTAURKAAURKBCDC7
SCHEMBL29790049 0.68 KDM4E (0.45) KDM4EHTTSIRT3TDP1CDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES INC (US) 2026-05-07 US claimed
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES INC (US) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS ZC3HAV1, CCR1, CCR6 KDM4E 427/4885HTT 4543/4885SIRT3 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.